These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16381669)

  • 1. Novel metabolites of buprenorphine detected in human liver microsomes and human urine.
    Chang Y; Moody DE; McCance-Katz EF
    Drug Metab Dispos; 2006 Mar; 34(3):440-8. PubMed ID: 16381669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.
    Picard N; Cresteil T; Djebli N; Marquet P
    Drug Metab Dispos; 2005 May; 33(5):689-95. PubMed ID: 15743975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.
    Moody DE; Slawson MH; Strain EC; Laycock JD; Spanbauer AC; Foltz RL
    Anal Biochem; 2002 Jul; 306(1):31-9. PubMed ID: 12069411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
    Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
    Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) by human liver microsomes: characterization of metabolic pathways and of cytochrome P450 isoforms involved.
    Baek MS; Kim JY; Myung SW; Yim YH; Jeong JH; Kim DH
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):381-8. PubMed ID: 11259320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
    Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
    Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.
    Prueksaritanont T; Dwyer LM; Balani SK; Theoharides AD
    Drug Metab Dispos; 1994; 22(2):281-8. PubMed ID: 7516854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolism studies of nomifensine monooxygenation pathways: metabolite identification, reaction phenotyping, and bioactivation mechanism.
    Yu J; Brown DG; Burdette D
    Drug Metab Dispos; 2010 Oct; 38(10):1767-78. PubMed ID: 20595377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes.
    Minato K; Suzuki R; Asagarasu A; Matsui T; Sato M
    Drug Metab Dispos; 2008 May; 36(5):831-40. PubMed ID: 18238859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
    Aprile S; Del Grosso E; Tron GC; Grosa G
    Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Huang W; Moody DE; McCance-Katz EF
    Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of in vitro metabolites of luotonin A in human liver microsomes using electrospray/tandem mass spectrometry.
    Lee S; Lee J; Jahng Y; Jeong TC; Kim DH
    Xenobiotica; 2013 Jun; 43(6):527-33. PubMed ID: 23256623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of magnolin and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes.
    Kim DK; Liu KH; Jeong JH; Ji HY; Oh SR; Lee HK; Lee HS
    Xenobiotica; 2011 May; 41(5):358-71. PubMed ID: 21294626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of sulfinpyrazone sulfide and sulfinpyrazone by human liver microsomes and cDNA-expressed cytochrome P450s.
    He M; Rettie AE; Neal J; Trager WF
    Drug Metab Dispos; 2001 May; 29(5):701-11. PubMed ID: 11302937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel metabolic pathways of pioglitazone in hepatocytes: N-glucuronidation of thiazolidinedione ring and sequential ring-opening pathway.
    Uchiyama M; Fischer T; Mueller J; Oguchi M; Yamamura N; Koda H; Iwabuchi H; Izumi T
    Drug Metab Dispos; 2010 Jun; 38(6):946-56. PubMed ID: 20185540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative metabolism of four limonoids in human liver microsomes using ultra-high-performance liquid chromatography coupled with high-resolution LTQ-Orbitrap mass spectrometry.
    Ren W; Xin SK; Han LY; Zuo R; Li Y; Gong MX; Wei XL; Zhou YY; He J; Wang HJ; Si N; Zhao HY; Yang J; Bian BL
    Rapid Commun Mass Spectrom; 2015 Nov; 29(21):2045-56. PubMed ID: 26443405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.